Literature DB >> 12390

Comparison of newly synthesized beta-adrenergic blockers, OPC 1085 and SQ 11725, with pindolol and propranolol in the blood-perfused canine SA node and papillary muscle preparations.

K Hashimoto, T Kimura, Y Yabuuchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 12390     DOI： 10.1254/jjp.26.504

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN： 0021-5198


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Kushida; Y Horai; K Chiba; T Suganuma
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.

Authors:  A Tarkiainen; K Saraste; T Seppälä; A Gordin; J Auvinen
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

3.  Concentration-effect and time-effect relationships of carteolol.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Chiba; T Suganuma; K Kushida
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Pharmacokinetics of carteolol in patients with impaired renal function.

Authors:  M Amemiya; K Tabei; H Furuya; Y Sakairi; Y Asano
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Pharmacokinetics of carteolol in relation to renal function.

Authors:  G Hasenfuss; M Schäfer-Korting; H Knauf; E Mutschler; H Just
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.